PANCREATIC CANCER, ADULT
Clinical trials for PANCREATIC CANCER, ADULT explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC CANCER, ADULT trials appear
Sign up with your email to follow new studies for PANCREATIC CANCER, ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to boost surgery success in tough pancreatic cancer
Disease control Not yet recruitingThis study tests whether adding the drug surufatinib to standard chemotherapy before and after surgery helps people with high-risk or borderline resectable pancreatic cancer. About 106 adults aged 18-75 will be randomly assigned to receive either the combination or chemo alone. T…
Matched conditions: PANCREATIC CANCER, ADULT
Phase: PHASE3 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated May 26, 2026 10:56 UTC
-
Promising drug combo targets tough pancreatic cancers in new trial
Disease control Not yet recruitingThis study tests whether adding the drug nimotuzumab to standard chemotherapy (nab-paclitaxel and gemcitabine) helps people with high-risk pancreatic cancer that can be surgically removed. About 156 adults will receive either the drug combination or a placebo before and after sur…
Matched conditions: PANCREATIC CANCER, ADULT
Phase: PHASE2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Can worrying worsen pancreatic cancer? new study investigates the mind-body link.
Knowledge-focused Not yet recruitingThis study follows 320 adults with pancreatic cancer to see if ongoing stress, anxiety, or poor sleep is linked to shorter survival or worse treatment response. Participants fill out simple questionnaires about their mood and sleep and give a small blood sample at regular visits.…
Matched conditions: PANCREATIC CANCER, ADULT
Sponsor: Shanghai Zhongshan Hospital • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC